A privately held biotech company based in San Diego, CA dedicated to developing next-generation genetic therapies for Duchenne and other muscle diseases. The company's lead program is a gene editing therapy for Duchenne muscular dystrophy.
Leadership & Board
Current Number of Employees5
Current LinkedIn Followers931
Latest Estimated Valuation
Estimated Valuation―
Estimated Valuation―
Total Amount Raised$400K
Total Amount Raised$400K
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$400K
Latest Funding Amount$400K
Latest Funding RoundInvestment
Latest Funding RoundInvestment
Post-Money Valuation―
Post-Money Valuation―
Employee Trend
MyoGene Bio had 5 employees as of September 14, 2026. The number of employees increased by 0 (0.00%) week-over-week.
5Latest Employee Count
0(0.00%)Week-Over-Week Change
Employee Trend serves as a data-driven indicator of company growth and expansion. The measurement reflects how a company’s workforce size changes over time.
Social Trend
MyoGene Bio had 931 followers as of September 14, 2026. The number of followers increased by 0 (0.00%) week-over-week.
931Latest Followers Count
0(0.00%)Week-Over-Week Change
LinkedIn Follower Trend serves as a data-driven indicator of market interest and company visibility. The measurement reflects how a company’s LinkedIn follower count changes over time.